Interestingly, some cancers with mutant p53, particularly early-stage cancers, are heterozygous, and the mutant p53 dimers form an inactive heterotetramer with wt-p53 dimers, acting as dominant negatives and neutralizing the wt-p53 activity [20,110,111]. Here, TP53 is linked to cancer.